Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study
- Type
- Retraction
- Notice date
- 3/18/2020 0:00
- Journal
- Journal of Neurology
- Publisher
- Springer
- Notice DOI
- 10.1007/s00415-020-09791-7
- Original paper DOI
- 10.1007/s00415-018-8809-8